ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 668269 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 668269; 2) Community: the network communities that were significantly associated with the response to NSC 668269; 3) Molecule: the relationships between components within communities and NSC 668269; 4) MDR: the compounds that were significantly associated with the NSC 668269.

NSC Compound Enrichment Correlation
NSC 670789 9-[(Z)-Bromoiodomethylidene]-9,10-dihydrophenanthrene-10-one 0.0174989034030623 0.54432144
NSC 673348 9,10-Anthracenedione, 1-[(oxiranylmethyl)amino]- 0.0174989034030623 0.25745591
NSC 681643 Camptothecin Derivative 0.0174989034030623 -0.014529338
NSC 682452 Benzo[1,2-b:5,4-b']dithiophene-4,8-dione, 2,5-diacetyl- 0.0174989034030623 0.21801175
NSC 692579 Null 0.0174989034030623 0.27617289
NSC 705331 2-Propenamide, N-(1,1-dimethylethyl)-N-(phenylmethyl)- 3-(phenylsulfinyl)-, (2Z)- 0.0174989034030623 0.42983387
NSC 708559 Benzeneacetamide, 3,4-dichloro-N-methyl-N-[3- [(methyl)[3-(1-pyrrolidinyl)propyl]amino]propyl]-, diethanedioate (dioxalate) 0.0174989034030623 0.20224221
NSC 710716 Null 0.0174989034030623 0.68516572
NSC 758881 Orlistat (USAN) 0.0174989034030623 0.12909074
NSC 623639 Cyclopentane-1,3-dimethanamine, N,N,N,N',N',N'-hexamethyl-2-oxo-, iodide 0.0178844438004191 0.68963699
Total:66  Current:25    [First] [Prev] [Next] [Last]